Change in Bone Mass after Gluten free Diet in Celiac disease Patients with Gastrointestinal and Non-Gastrointestinal Presentations: An Interventional Study
DOI:
https://doi.org/10.37506/sbcs2d06Keywords:
Atypical celiac, Bone Health, Gluten free diet.Abstract
Background and aim: Celiac disease (CD) is an autoimmune enteropathy and gluten free diet (GFD) is the only treatment available till now. Although previous studies had shown that patients with non-gastrointestinal symptoms have osteopenia but there is scanty literature on the effect of GFD on Bone Mass Density (BMD) improvement in celiac disease patients with or without gastrointestinal symptoms in childhood.
Methods :A prospective interventional study was conducted in a tertiary care institute in which newly diagnosed children 1 to 14 years of age presented to Pediatrics OPD or admitted in ward with symptoms suggestive of CD and IgA tissue transglutaminase level 10 folds of normal level were taken as cases. Children with other associated diseases like Type 1 Diabetes Mellitus, Hypothyroidism and who were non-compliant to GFD diet were excluded. Those children were later grouped into as children with gastrointestinal and children with non-gastrointestinal symptoms. DEXA scan was done in both the groups at presentation and after 6 months of gluten free diet to determine bone mass density. The results were later compiled and analysed . P value of <0.05 was taken as significant.
Results: A total of 50 patients were enrolled in the study in which 25 patients were in each group. In children with gastrointestinal symptoms, 10 (40%) children had osteopenia (Z-score below -1) and 2 patients had severe osteopenia (Z-score below -2.5) where as in other group with non-gastrointestinal symptoms, 11(44%) has osteopenia and 3 had severe osteopenia. After 6 months of GFD there was significant improvement in mean Z-score, mean BMD and mean BMC(p<0.001) in both the groups however complete restoration was not achieved.
Conclusions: Our study clearly showed that children without gastrointestinal symptoms had osteopenia of almost same degree as children with these symptoms (p >0.05). There is a significant beneficial effect of GFD on bone mass in both the groups (gastrointestinal as well as non-gastrointestinal) separately. Such results emphasize early detection and role of GFD in
treatment of osteopenia in these children to have adequate bone mass in the puberty.
References
Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. ESPGHAN guidelines for the diagnosis celiac disease in children and adolescents: an evidence- based approach. J Pediatr Gastroenterol Nutr2012;54:136-60.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-92.
Sher KS, Fraser RC, Wicks AC, Mayberry JF. High risk of coeliac disease in Punjabis. Epidemiological study in the South Asian and European populations of Leicestershire. Digestion 1993;54:178-82.
Zanchi C, Di Leo G, Ronfani L, Stefano M, Not T. Bone metabolism in celiac disease. J Pediatr2008;153:262-5.
Hassan K, Kader AH. Celiac disease: the search for adjunctive or alternative therapies. Expert Rev Gastroenterol Hepatol 2014;8:313-21.
Makharia GK. Current and emerging therapy for celiac disease. Front Med (Lausanne) 2014;1:6-8.
Binkovitz LA, Henwood MJ. Pediatric DXA: technique and interpretation .Pediatr Radiol 2007;37:21-31.
Sahin Y. Clinical evaluation of children with celiac disease: A single-center experience. Arch Clin Gastroenterol 2020;6:26-30.
Bhattacharya M, Kapoor S, Dubey AP. Celiac disease presentation in a tertiary referral centre in India: current scenario. Indian J Gastroenterol 2013;32:98-102.
Gomes RC, Maia JC, Arrais RF, Jatoba CAN, Rocha MAC, et al.The celiac iceberg: from the clinical spectrum to serology and histopathology in children and adolescents with type 1 diabetes mellitus and Down syndrome. Scand J Gastroenterol2016;51:178-85.
Khatib M, Baker RD, Ly EK, Kozielski R, Baker SS. Presenting pattern of pediatric celiac disease. JPGN 2016;62:60-63.
Hota D, Bhalla K, Nanda S, Gupta A, Mehra S. Beneficial effects of gluten free diet on IgA tissue transglutaminase levels and various growth parameters in celiac disease patients. J Family Med Prim Care 2019;8:823-7.
Balamtekin N, Uslu N, Baysoy G, Usta Y, Demir H, Saltik-Temizel IN, et al. The presentation of celiac disease in 220 Turkish children. Turk J Pediatr2010;52:239-44.
Saeed A, Assiri A, Assiri H, Ullah A, Rashid M. Celiac disease in Saudi children : evaluation of clinical features and diagnosis. Saudi Med J 2017;38:895-9.
Tau C, Mautalen C, De Rosa S, Roca A, Valenzuela X. Bone mineral density in children with celiac disease. Eur J Clin Nutr2006;60:358-63.
Mora S, Barera G, Ricotti A, Weber G, Bianchi C, Chiumello G. Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr1998;67:477-81.
Kalayci AG, Kansu A, Girgin N, Kucuk O. Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics 2001;108:89-91.
Micic D, Rao V, Semrad CE. Celiac disease and its role in the development of metabolic bone disease. J Clin Densitom. 2020;23:190–9.
Bianchi ML, Bardella MT. Bone in celiac disease. Osteoporos Int. 2008 Dec;19(12):1705-16.
Bardella MT, Bianchi ML, Teti A. Chronic inflammatory intestinal diseases and bone loss. Gut. 2005 Oct;54(10):1508.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en